Month: November 2018

The Proposed New FDA Rule Brings Changes To Informed Consent for Clinical Studies

11/23/2018

The Diagnostic and Interventional Cardiology website posted an important article about recent proposed changes by the FDA which may allow Institutional Review Boards (IRB) to waive or alter informed consent requirements for clinical studies that pose minimal risk to human participants. The conditions under which an IRB could do this are limited and detailed in the…

Read More

Meet with Christopher Kata at DeviceTalks West 2018 December 11th & 12th!

11/19/2018

Meet with Christopher Kata, Director of Sales & Marketing on December 11th & 12th 2018 DEVICETALKS West ! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: December 11th & 12th 9:00 am – 5:30 pm Where: HILTON ORANGE COUNTY / COSTA MESA, 3050 Bristol St, Costa Mesa, CA 92626 Registration: https://west.devicetalks.com/      …

Read More

Meet With Christopher Kata at the “Talking to Doctors & Patients: Using Primary Market Research Data to Seal the Deal with Investors” Event on November 13th!

11/05/2018

Meet with Christopher Kata, Director of Sales & Marketing on November 13th at the OBIO Event “Talking to Doctors & Patients: Using Primary Market Research Data to Seal the Deal with Investors”! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 13th 11:00 am – 2:00 pm Where: 100 College St Suite 150…

Read More

You're Going to be Amazed By TrialStat

With TrialStat your studies will run smoothly, on-time and within budget.

Your Study Coordinators will enjoy the intuitive user interface and the speed in which they can enter their data. Schedule your personalized demo today to see first hand how TrialStat will transform your studies!

Close